Wikidata

(Q63229328)

English

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Evaluation of Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir Plus Ribavirin Based Therapy for Chronic Hepatitis C With or Without Compensated Cirrhosis in Haemodialysis Patients (English)
0 references
medical condition
hepatitis
0 references
hepatitis A
0 references
hepatitis C
0 references
country
Egypt
0 references
start time
9 November 2016
0 references
end time
January 2018
0 references
number of participants
40
0 references
research intervention
ribavirin
0 references
ritonavir
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63229328&oldid=2149411534"